ACT NOW: Tell the FDA to say NO to Pfizer jabs for babies and toddlers

Our Stand: At-A-Glance

  • FDA’s VRBPAC will meet June 15, 2022, to discuss expanding the EUA for Pfizer’s COVID jab to children from 6 months up to 5 years old.
  • This meeting was first scheduled for February, but after a huge public outcry the meeting was postponed to collect more data. As of June 3, 2022, this meeting has not yet been announced in the Federal Register (as the other June 2022 meetings have been) but comments are open.
  • This authorization would make approximately 18 million more children eligible for an experimental jab.
  • In December 2021, Pfizer announced the two-dose series wasn’t successful and did not provide immunity in 2–5-year-olds. Our youngest children will have to get more.
  • This age group is at minimal risk for catching or passing on COVID. If a child gets infected, they are far less likely to have serious outcomes.
    • According to data published by the CDC, 99.99815% of children who contract COVID-19 survive.
    • Most COVID cases are spread from adult to children and our children are not a threat to the older population.
  • This is not an FDA-approved shot; this would be an expansion of the experimental Emergency Use Authorization.
  • There are no long-term safety studies for this age group, or any age group, for the mRNA COVID shots because the placebo group was “unblinded” and allowed to get the jab.
  • If the FDA expands the Pfizer EUA to children as young as 5, systems are already in place to distribute the jab to our most vulnerable and schools will increase COVID jab mandates for our children. The ultimate goal for the White House is to expand the vaccine authorization to all children and get the jab on the ACIP Vaccine Schedule.
  • You can help stop this. You must tell our government what you want for your children. You can make a public comment that will go on record for the FDA to consider as it decides on Emergency Use Authorization for COVID vaccines for children ages 6 months – 4 years.
  • Comments received on or before June 7, 2022, will be provided to the committee. However, if you miss that window, you can still comment! The docket will remain open until the meeting, become part of our nation’s public record, and be taken into consideration by the FDA.

Sample Topics for Comments:

  • Ask the FDA to do their job and require adequate data.
  • Tell the FDA they must pay attention to the safety signal from VAERS and make decisions based on extreme caution.
  • The FDA must make decisions independent of what parents want for their children.
  • Ask questions that the FDA should be asking
    • Have they examined new evidence that the spike protein circulates through the body?
    • Do they know the rates of transmission from children to adults?
    • What is the effect of the COVID shot on puberty and fertility?
  • Have you been reading the documents Pfizer is releasing under court order?
  • Where is your evaluation of natural immunity in this decision?

Your home address information is required from the legislative offices to ensure you are reaching out to your designated representatives. Your email and your phone number are used to establish connection with your designated representatives. Messages from non-constituents don't have the same impact on a legislator as messages from verified constituents, who can vote for that officeholder. We do not share your name and contact information with any third parties unless legally required to do so.

Have a question or need help?

Our Stand: The Full Story

The FDA is responsible for evaluating the safety and efficacy of drugs and biologics that come to market. American parents rely on that. But many vaccines and drugs have been recalled because they hurt people they were supposed to help, even after they were recommended by VRBPAC and put through years of evaluation before approval by the FDA. The COVID shots went through research and development in an astounding four months, a process that generally takes up to a decade for vaccines. The first trial in adults began April 23, 2020. Trials in children as young as 6 months started March 24, 2021. As of June 15, 2022, when VRBPAC will meet to evaluate the data from Pfizer and make a recommendation to the FDA on whether the EUA for Pfizer’s COVID shots should be extended to children as young as 6 months, there will only be just over two years of data for adults and one year of data for children. In this short amount of time, there is already significant data about adverse events that has not yet been properly analyzed from VAERS, which is a huge safety signal that these shots are not safe.

Already, hundreds of adverse events have been reported to VAERS for children ages 0-5 after COVID shots given to breastfeeding mothers. One 6-month-old infant died within 24 hours of breast milk exposure following his mother’s second shot (VAERS ID 1166062-1). Another infant suffered a seven-minute seizure after breastfeeding and reports a permanent disability – no medical history or other complicating factors were found (VAERS ID 1415059-1). Many other breastfed infants suffered anaphylaxis, blisters, rashes, fevers, racing heartbeats, and more, requiring hospitalizations, emergency care, and visits to their doctors.

There have been 1,492 reports to VAERS after COVID shots in 3–5-year-olds as of June 2, 2022. One 5-year-old died (VAERS ID 1890705-1), four report life threatening events, five report permanent disability. Most of the adverse events reported were from a Pfizer shot, the very manufacturer that has submitted an application to extend their EUA experimental shots into children as young as 6 months old.

Do we know that the spike protein stays in the place it is injected, or does it travel through the body and end up being found in places like sex organs? If the spike protein travels, would it be more likely to end up in the brain and CNS of infants and toddlers since the blood brain barrier is not as developed? One Canadian immunologist and vaccine researcher, Bryam Bridle, believes the spike protein does not stay at the vaccination site, but instead can travel through the body in the blood.[i] Do the unique differences in the immune systems of infants change the analysis for immediate safety and long-term safety – clearly it has already been demonstrated that the efficacy of the jab is not the same, and it is logical to assume the safety profile would be different in undeveloped immune systems, as well. Babies have different ratios of fat to muscle, as well as different metabolisms – are these things taken into consideration in the trials?

Should we be vaccinating children to (possibly) protect adults? Dr. James Hildebrant, who sits on VRBPAC, does not think so, but he voted yes for the shots in children as young as 5. Is there enough evidence that children transmit the COVID virus to adults? Does it make sense that our smallest humans would get doses of an experimental drug that has only a couple years’ worth of post-market safety data in other age groups?

Despite all these questions, the White House has been waiting for this authorization since January. Jeffrey Zientz, former White House COVID-19 Response Coordinator, told the press the administration was ready to “hit the ground running” to vaccinate infants and toddlers as soon as they get the authorization.

We need to remind VRBPAC and the FDA their job isn’t to approve something because parents are scared. Their job isn’t to move a political agenda down the line or make good on the White House’s advance purchase contracts. Their job is to keep American families safe and only allow effective products to market.

The FDA must take into consideration public comment as well as the advice of VRBPAC when making decisions about novel biologics that enter the U.S. market. Commenting in the Federal Register (the publication for all federal agency actions) is a simple yet powerful way to make your voice heard.

Click the button to comment!

Take Action

Share This